Skip to main content
Powered by
buzzwords.news
(
US Patent 11,232,363 B2
) · created by
d-e-v.com
buzzwords.technology
main_menu
Home
Channels
Personalize
Headlines
Alexa Skill
Search
Search
Home
Headlines
US FDA approves Ionis-AstraZeneca's nerve disease drug
posted:
Thu, 12/21/2023 - 17:45 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
BioNTech Bags FDA Breakthrough Therapy Designation For BNT323/DB-1303
posted:
Thu, 12/21/2023 - 09:02 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Calliditas Therapeutics' Kidney Disease Drug Gets FDA Approval; Stock Surges
posted:
Wed, 12/20/2023 - 20:07 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Ocugen Granted FDA RMAT Designation For OCU400
posted:
Tue, 12/19/2023 - 08:48 EST
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Lexeo Therapeutics Says FDA Grants Fast Track And Orphan Drug Designation To LX2020
posted:
Mon, 12/18/2023 - 07:25 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
US FDA approves Merck's drug for kidney cancer
posted:
Thu, 12/14/2023 - 18:01 EST
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Erasca: FDA Grants Fast Track Designation To Naporafenib In Combination With Trametinib
posted:
Mon, 12/11/2023 - 08:33 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Basilea Pharma: Astellas Pharma Gets FDA Approval For Cresemba's Expanded Use In Kids With IA, IM
posted:
Mon, 12/11/2023 - 02:08 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
BD Gets FDA 510(k) Clearance For Fingertip Blood Collection Device
posted:
Thu, 12/07/2023 - 07:01 EST
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Ipsen : FDA Grants Priority Review To Elafibranor NDA For Rare Cholestatic Liver Disease Treatment
posted:
Thu, 12/07/2023 - 01:23 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Novartis' Fabhalta Gets FDA Approval To Treat Paroxysmal Nocturnal Hemoglobinuria In Adults
posted:
Wed, 12/06/2023 - 01:15 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Lilly's Jaypirca Gets Second Approval From FDA
posted:
Sat, 12/02/2023 - 11:46 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
FDA Clears Biora's IND Application For BT-600 In Ulcerative Colitis Treatment; Stock Surges
posted:
Thu, 11/30/2023 - 22:55 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
FDA Evaluates China-made Plastic Syringes For Potential Device Failures
posted:
Thu, 11/30/2023 - 21:23 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Astellas : FDA Grants Priority Review For SBLA Of Padcev Combination For Bladder Cancer Treatment
posted:
Thu, 11/30/2023 - 20:52 EST
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Pagination
Previous page
‹‹
Page 8
Next page
››